Equity Investment |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Equity Method Investments and Joint Ventures [Abstract] | |
| Equity Investment | Note 7 – Equity Investment
On May 21, 2025, the Company invested $100,000 in TG-17, Inc. (“TG-17”), a privately held Delaware corporation, in exchange for shares of TG-17 Series CF Preferred Stock. The investment represents less than 20% of the outstanding equity of TG-17 and does not convey board representation, control rights, or any significant influence over the investee’s operating or financial policies.
The investment does not have a readily determinable fair value, and accordingly, the Company accounts for the investment using the measurement alternative. Under this method, the investment is recorded at its original cost and is adjusted for any impairment or for observable price changes in orderly transactions for the identical or a similar investment of the same issuer.
As of December 31, 2025, the Company has not identified any events or changes in circumstances that would indicate impairment of the investment, nor has it observed any transactions requiring a remeasurement of its carrying value. The investment is classified as a non-current asset as a component of other long-term assets on the Company’s consolidated balance sheet.
|